Journal for ImmunoTherapy of Cancer (Nov 2023)
770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)